Carisma Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Carisma Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Carisma Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $2.32M, a 39.5% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.32M +$658K +39.5% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $1.95M -$1.1M -36.2% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $5.15M +$1.66M +47.4% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.17M -$2.65M -54.9% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $1.66M +$1.66M Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $3.05M +$3.01M +7207% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $3.49M +$3.39M +3393% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $4.82M +$4.7M +3811% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $0 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $41.7K Jun 30, 2022 10-Q/A 2022-08-25
Q1 2022 $100K Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $123K Dec 31, 2021 10-K 2023-02-28
Q4 2018 $200K Jan 1, 2019 10-K 2021-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.